1386399-13-8

Basic information

• Product Name: (3-bromophenyl)(2,4-dichloropyrimidin-5-yl)methanol
• Synonyms: (3-bromophenyl)(2,4-dichloropyrimidin-5-yl)methanol
• CAS NO: 1386399-13-8
• Molecular Weight: 333.999
• Mol File: 1386399-13-8.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: (3-bromophenyl)(2,4-dichloropyrimidin-5-yl)methanol(CAS DataBase Reference)
• NIST Chemistry Reference: (3-bromophenyl)(2,4-dichloropyrimidin-5-yl)methanol(1386399-13-8)
• EPA Substance Registry System: (3-bromophenyl)(2,4-dichloropyrimidin-5-yl)methanol(1386399-13-8)

Safety Data

• Hazardous Substances Data: 1386399-13-8(Hazardous Substances Data)

Usage

General Description

(3-bromophenyl)(2,4-dichloropyrimidin-5-yl)methanol is a chemical compound with the formula C11H7BrCl2N2O. It is a white crystalline solid that is used as an intermediate in the synthesis of pharmaceuticals and agrochemicals. (3-bromophenyl)(2,4-dichloropyrimidin-5-yl)methanol is a versatile building block for the preparation of various biologically active molecules and has potential applications in drug discovery and development. Its unique structure and reactivity make it a valuable tool for chemical research and synthesis. As a result, (3-bromophenyl)(2,4-dichloropyrimidin-5-yl)methanol is of interest to both the pharmaceutical and chemical industries for its potential as a key ingredient in the production of new drugs and agrochemicals.

Upstream product

• 36082-50-5 2,4-dichloro-5-bromopyrimidine 
• 3132-99-8 m-bromobenzoic aldehyde 

Downstream Products

• 1386399-29-6 {4-[3-(3-benzylamino-phenyl)-1-(2-trimethylsilanyl-ethoxymethyl)-1H-pyrazolo[3,4-d]pyrimidin-6-ylamino]-cyclohexyl}-carbamic acid tert-butyl ester 
• 1386399-23-0 [3-(3-benzylamino-phenyl)-1-(2-trimethylsilanyl-ethoxymethyl)-1H-pyrazolo[3,4-d]pyrimidin-6-yl]-(2-morpholin-4-yl-ethyl)-amine 
• 1386399-51-4 (4-{3-[3-(3-tert-butoxycarbonylamino-1-phenyl-propylamino)-phenyl]-1-trityl-1H-pyrazolo[3,4-d]pyrimidin-6-ylamino}-cyclohexyl)-carbamic acid tert-butyl ester 
• 1386398-58-8 N-{3-[3-(3-amino-1-phenyl-propylamino)-phenyl]-1H-pyrazolo[3,4-d]pyrimidin-6-yl}-cyclohexane-1,4-diamine hydrochloride 
• 1386398-52-2 N₁-{3-[6-(2-morpholin-4-yl-ethylamino)-1H-pyrazolo[3,4-d]pyrimidin-3-yl]-phenyl}-1-phenyl-propane-1,3-diamine hydrochloride 
• 1386399-35-4 {4-[3-{3-[(thiophen-3-ylmethyl)-amino]-phenyl}-1-(2-trimethylsilanyl-ethoxymethyl)-1H-pyrazolo[3,4-d]pyrimidin-6-ylamino]-cyclohexyl}-carbamic acid tert-butyl ester 
• 1386398-37-3 N-(3-{3-[(thiophen-3-ylmethyl)-amino]-phenyl}-1H-pyrazolo[3,4-d]pyrimidin-6-yl)-cyclohexane-1,4-diamine 

Relevant articles and documents

PYRAZOLO PYRIMIDINES AS DYRK1A AND DYRK1B INHIBITORS

Compounds of formula and pharmaceutically acceptable salts thereof are described, as well as the pharmaceutical compositions containing said compounds and their pharmaceutically acceptable salts, and the use of said compounds and pharmaceutical compositions for the treatment, control or amelioration of proliferative diseases, including cancer, Down syndrome or early onset Alzheimer's disease.